Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy

Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Fan Tong, Hanmei Li, Huile Gao, Yuan Li
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	AAV Gene therapy Tumor specific delivery IL-12 Cancer immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383525003715
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model
by: Chuyuan Chen, et al.
Published: (2025-06-01)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
by: Marina Pavlou, et al.
Published: (2021-02-01)

Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
by: Lei Zhang, et al.
Published: (2025-09-01)

αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues
by: Olaniyi Olarewaju, et al.
Published: (2024-12-01)

iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
by: Estelle Berreur, et al.
Published: (2025-06-01)

DYNAMICS OF IL12 CYTOKINE EXPRESSION IN HUMAN MACROPHAGES AFTER TREATMENT WITH DIOXIN
by: D. Y. Oshchepkov, et al.
Published: (2015-01-01)

IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
by: Xiaoyu Cui, et al.
Published: (2025-06-01)

Artificial Intelligence‐Based Approaches for AAV Vector Engineering
by: Fangzhi Tan, et al.
Published: (2025-03-01)

The Role of Interleukin-6, and IL-12+p40 in the Development of Ischemic Heart Disease
by: Dina A. A. Al-Roubaey, et al.
Published: (2023-06-01)

Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy
by: Lanfang Ren, et al.
Published: (2025-05-01)

Effective delivery of large genes to the retina by dual AAV vectors
by: Ivana Trapani, et al.
Published: (2013-12-01)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
by: Paul G. Pavicic, et al.
Published: (2023-12-01)

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
by: Marika Marino, et al.
Published: (2022-03-01)

AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
by: Liyan Zhang, et al.
Published: (2024-12-01)

A novel platform for engineered AAV-based vaccines
by: Sabrina Babutzka, et al.
Published: (2025-03-01)

Clinical and genetic features of IL12Rb1 deficiency: Single center experience of 18 patients
by: Çağman Tan, et al.
Published: (2016-08-01)

Reversing Pathology in an Aggravated Fabry Mouse Model Using Low-Dose Engineered Human Alpha-Galactosidase A AAV Gene Therapy
by: Wanida Ruangsiriluk, et al.
Published: (2025-02-01)

AAV-regulated Serpine2 overexpression promotes hair cell regeneration
by: Qiuhan Sun, et al.
Published: (2024-12-01)

New possibilities of allergen-specific immunotherapy in relation to the induction of antiviral immunity in patients with bronchial asthma
by: A. V. Maksimova
Published: (2024-06-01)

SECRETION OF IL-12, IL-27 BY MONONUCLEAR LEUKOCYTES AND EXPRESSION OF THEIR RECEPTORS ON T-LYMPHOCYTES IN CONDITIONS OF DIRECTED CELL INDUCTION IN VITRO IN PULMONARY TUBERCULOSIS
by: I. E. Esimova, et al.
Published: (2014-08-01)

IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality
by: M. Vidal-Manrique, et al.
Published: (2025-12-01)

Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
by: Mitsuki Kosaka, et al.
Published: (2025-06-01)

Common AAV gene therapy vectors show nonselective transduction of ex vivo human brain tissue
by: JP McGinnis, et al.
Published: (2025-06-01)

Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control
by: Taryn Diep, et al.
Published: (2025-03-01)

Fusion of Visual Attention and Scene Descriptions With Deep Reinforcement Learning for AAV Indoor Autonomous Navigation
by: Hussein Samma, et al.
Published: (2025-01-01)

Probing aspects of extracellular vesicle associated AAV allows increased vector yield and insight into its transduction and immune-evasive properties
by: Ming Cheng, et al.
Published: (2025-03-01)

Abnormalities of IL-12 Family Cytokine Pathways in Autosomal Dominant Polycystic Kidney Disease Progression
by: Corina-Daniela Ene, et al.
Published: (2024-11-01)

A comprehensive study of AAV tropism across C57BL/6 mice, BALB/c mice, and crab-eating macaques
by: Kailun Fang, et al.
Published: (2025-03-01)

Secreted PD-L1 alleviates inflammatory arthritis in mice through local and systemic AAV gene therapy
by: Wenjun Li, et al.
Published: (2025-02-01)

Spatial genomics uncovers cytokines promoting ovarian tumour heterogeneity and immunotherapy resistance
by: Gurkan Mollaoglu, et al.
Published: (2025-02-01)

Intention Recognition of AAV Swarm Based on GAT-EPool-BiGRU Model
by: Jiajun Yuan, et al.
Published: (2025-01-01)

AAV-mediated transduction of songbird retina
by: Pranav Kumar Seth, et al.
Published: (2025-03-01)

Immunotherapy and delivery systems for melanoma
by: Hui Liu, et al.
Published: (2024-12-01)

Distinct infectivity and neutralization antibody responses in the highly homologous AAV Go.1 and AAV5
by: Mei Li, et al.
Published: (2025-04-01)

Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab
by: Arfenya E. Karamova, et al.
Published: (2025-03-01)

A versatile cell line for establishing potency of cell type-specific AAV transgenes
by: Refugio A. Martinez, et al.
Published: (2025-03-01)

AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway
by: Yalan Cheng, et al.
Published: (2023-06-01)

Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
by: Livia Zhou, et al.
Published: (2024-12-01)

Development of circular AAV cargos for targeted seamless insertion with large serine integrases
by: Brett J.G. Estes, et al.
Published: (2025-06-01)

Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer
by: Angela L. Hughson, et al.
Published: (2024-12-01)